focus -WSS

focus

author：Wikipedia 2025-10-02 20:48:16 - browse：46824

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the fourth quarter:

The Food and Drug Administration’s decision in June to grant conditional approval to a gene therapy for Duchenne muscular dystrophy was a watershed moment for the treatment of the neuromuscular disease, and a big win for its maker, Sarepta Therapeutics. Confirming the gene therapy’s benefit — and potentially broadening its use to include older boys — will be determined by a Phase 3 clinical trial that will read out later this quarter.

Pfizeris developing its own gene therapy for Duchenne in a fully enrolled Phase 3 study with final results expected in 2024. But before the verdict is revealed, Pfizer intends to conduct an interim analysis later this quarter. The most likely outcome of this early look will be a determination to continue the study to its completion. But surprises — including an early stop for overwhelming efficacy — can’t be ruled out.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Wikipedia

focus

WSS

Medical schools are missing the mark on artificial intelligence

AstraZeneca to buy developer of next

AstraZeneca to buy developer of next

Future doctors should be trained to promote social change

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

Baby aspirin cuts fat buildup in liver disease patients, in small study

explore

focus

entertainment

As demand for Covid shots wanes, Moderna seeks its next success

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

State Dept. review finds Biden bears some blame for Afghanistan failures

Baby aspirin cuts fat buildup in liver disease patients, in small study

Supreme Court strikes down use of affirmative action

Scientists find bacteria from stomach of ancient iceman

Hollywood unions extend contract negotiations for actors

Intermittent fasting comes with a heart risk? Not so fast

Activists slam private health insurers over coverage restrictions

New company forms to vet health AI models, root out weaknesses

focus

Virtual Event: March of the Biosimilars

Neuroscience’s long legacy of racism

Methadone treatment changes are coming. Do they go far enough?

U.K. researchers warn about biases in medical devices, algorithms

Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

5 to watch: Tech startups trying to solve health care's staffing crisis

Wikipedia

focus

Wikipedia

focus